What is Avalo Therapeutics's net income?

Avalo Therapeutics (AVTX) reported net income of -$19.63M in Q1 2026.

How has Avalo Therapeutics's net income changed year-over-year?

Avalo Therapeutics's net income decreased by 49.3% year-over-year, from -$13.15M to -$19.63M.

What is the long-term trend for Avalo Therapeutics's net income?

Over 4 years (2021 to 2025), Avalo Therapeutics's net income has grown at a -1.9% compound annual growth rate (CAGR), from -$84.38M to -$78.26M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Avalo Therapeutics AVTX Net Income

Net Income at other companies

Eli LillyLLY

$7.4B+168%

AbbVieABBV

$697M-45.9%

XencorXNCR

-$128.92M-165%

AbCellera Biologics Inc.ABCL

-$43.17M+5.4%

AnaptysBio, Inc.ANAB

-$52.88M-34.5%

Absci CorporationABSI

-$29.6M-12.3%

Other financials

Income statement

See full

Revenue$59.0K-69.3%

Gross profit$963.0K+8,855%

Operating income-$20.9M-42.5%

Net income-$19.6M-49.3%

EPS (diluted)-$0.98+21.6%

Balance sheet

See full

Cash & equivalents$25.3M-79.8%

Total debt$328.0K-59.1%

Total equity$68.3M-44.3%

Total assets$99.9M-27.9%

Cash flow

See full

Operating cash flow-$17.7M-87.1%

CapEx-—

Free cash flow-$15.0M-444%

Valuation

See full

Market cap$954.59M+1,800%

Enterprise value$929.6M-1,353%

P/S1,909.2×+1,868×

Profitability

See full

Gross margin182%+176pp

Operating margin-15,536.1%-17,275pp

Net margin-7,965.8%-10,750pp

FCF margin-11,123.8%-13,374pp

Returns & leverage

See full

Return on equity-88.8%—

Debt / equity0×0.0×

Current ratio7.7×-14.9×

Where this comes from

Reported directly by Avalo Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Avalo Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avalo Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avalo Therapeutics's net income?: Avalo Therapeutics (AVTX) reported net income of -$19.63M in Q1 2026.
How has Avalo Therapeutics's net income changed year-over-year?: Avalo Therapeutics's net income decreased by 49.3% year-over-year, from -$13.15M to -$19.63M.
What is the long-term trend for Avalo Therapeutics's net income?: Over 4 years (2021 to 2025), Avalo Therapeutics's net income has grown at a -1.9% compound annual growth rate (CAGR), from -$84.38M to -$78.26M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.